双成药业
(002693)
| 流通市值：20.71亿 | | | 总市值：21.00亿 |
| 流通股本：4.11亿 | | | 总股本：4.17亿 |
| 报告期 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 3,712,099.53 | 43,357,569.67 | 5,920,315.43 | 12,196,777.95 |
| 应收票据及应收账款 | 16,412,902.45 | 16,748,246.87 | 22,768,230.27 | 27,537,744.6 |
| 其中：应收票据 | - | 17,098.2 | - | 273,500 |
| 应收账款 | 16,412,902.45 | 16,731,148.67 | 22,768,230.27 | 27,264,244.6 |
| 应收款项融资 | 594,662 | 238,880 | 100,000 | 595,240.8 |
| 预付款项 | 2,036,222.41 | 4,361,917.15 | 3,342,109 | 1,252,186.85 |
| 其他应收款合计 | 13,235,777.61 | 12,333,105.64 | 11,672,666.22 | 11,581,580.27 |
| 存货 | 79,379,114.26 | 76,188,987.53 | 70,769,123.9 | 65,412,951.12 |
| 其他流动资产 | 23,647.6 | 10,594.04 | 7,493.35 | 5,068.62 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 203,023,149.88 | 252,244,470.03 | 241,151,591.67 | 252,394,374.44 |
| 非流动资产: | | | | |
| 投资性房地产 | 8,445,883.25 | 8,563,790.48 | 8,681,697.71 | 8,794,355.24 |
| 固定资产 | 444,174,923.63 | 448,885,788.93 | 457,540,234.74 | 467,630,295.99 |
| 在建工程 | 14,896,907.99 | 8,524,933.85 | 3,659,307.42 | 4,135,542.25 |
| 无形资产 | 61,836,899.48 | 63,865,715.19 | 65,903,507.16 | 72,088,644.61 |
| 开发支出 | 111,958,010.76 | 103,326,713.55 | 96,743,142.32 | 92,816,455.21 |
| 长期待摊费用 | 4,128,751.48 | 3,666,722.5 | 3,985,817.5 | 3,485,971.46 |
| 递延所得税资产 | 865,601.81 | 865,601.81 | 970,228.42 | 970,228.42 |
| 其他非流动资产 | 12,133,682.26 | 13,205,725.67 | 12,148,917.38 | 8,702,921.46 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 658,440,660.66 | 650,904,991.98 | 649,632,852.65 | 658,624,414.64 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 861,463,810.54 | 903,149,462.01 | 890,784,444.32 | 911,018,789.08 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 14,710,285.15 | 13,904,811.96 | 15,437,617.37 | 15,497,904.84 |
| 应付账款 | 14,710,285.15 | 13,904,811.96 | 15,437,617.37 | 15,497,904.84 |
| 预收款项 | 1,756,342.26 | 2,258,678.26 | 824,274.65 | 1,423,153.21 |
| 合同负债 | 33,044,026.78 | 28,620,222.3 | 15,660,500.66 | 23,529,448.34 |
| 应付职工薪酬 | 5,871,471.23 | 5,932,981.02 | 5,860,557.02 | 8,596,015.63 |
| 应交税费 | 3,702,405.99 | 4,097,847.14 | 3,265,795.21 | 12,779,928.97 |
| 其他应付款合计 | 47,217,992.54 | 44,819,219.25 | 55,239,285.4 | 51,348,839.33 |
| 一年内到期的非流动负债 | 165,983,685.1 | 201,694,465.85 | 201,475,380.01 | 205,303,152.76 |
| 其他流动负债 | 1,142,167.11 | 566,657.83 | 777,014.84 | 883,316.47 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 273,428,376.16 | 301,894,883.61 | 298,540,425.16 | 319,361,759.55 |
| 非流动负债: | | | | |
| 递延收益 | 8,179,041.96 | 7,181,280.01 | 7,408,690.27 | 7,636,100.53 |
| 递延所得税负债 | 2,999,050.69 | 2,999,050.69 | 3,078,500.21 | 3,078,500.21 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 11,178,092.65 | 10,180,330.7 | 10,487,190.48 | 10,714,600.74 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 284,606,468.81 | 312,075,214.31 | 309,027,615.64 | 330,076,360.29 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 416,631,090 | 416,184,180 | 414,737,000 | 414,737,000 |
| 资本公积 | 376,426,188.66 | 374,481,664.17 | 369,692,405.49 | 368,982,987.72 |
| 减:库存股 | 4,011,000 | 4,011,000 | 8,022,000 | 8,022,000 |
| 其他综合收益 | -355,830.08 | -347,399.57 | -356,059.65 | -357,556.78 |
| 盈余公积 | 34,425,232.98 | 34,425,232.98 | 34,425,232.98 | 34,425,232.98 |
| 未分配利润 | -297,838,271.15 | -287,427,447.31 | -291,712,083.92 | -296,217,703.74 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 525,277,410.41 | 533,305,230.27 | 518,764,494.9 | 513,547,960.18 |
| 少数股东权益 | 51,579,931.32 | 57,769,017.43 | 62,992,333.78 | 67,394,468.61 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 576,857,341.73 | 591,074,247.7 | 581,756,828.68 | 580,942,428.79 |
| 负债和股东权益合计 | 861,463,810.54 | 903,149,462.01 | 890,784,444.32 | 911,018,789.08 |
| 公告日期 | 2023-10-28 | 2023-08-31 | 2023-04-27 | 2023-04-21 |
| 审计意见(境内) | | | | 标准无保留意见 |